KPRX · NASDAQ
Kiora Pharmaceuticals (KPRX) Stock Price & Fundamentals
Kiora Pharmaceuticals (KPRX) closed at $340.75 on Oct 9, 2026, up 1.29% from the previous close of $336.41.
Share price, past year
1Y +16.48%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $340.75 |
| Sep 30, 2026 | $336.10 |
| Aug 31, 2026 | $345.81 |
| Jul 31, 2026 | $353.76 |
| Jun 30, 2026 | $347.90 |
| May 29, 2026 | $334.76 |
| Apr 30, 2026 | $340.70 |
| Mar 31, 2026 | $331.32 |
| Feb 27, 2026 | $336.25 |
| Jan 30, 2026 | $296.89 |
| Dec 31, 2025 | $286.81 |
| Nov 28, 2025 | $291.40 |
| Oct 31, 2025 | $281.43 |
Key statistics
- Market cap
- $1.51B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.50
- Revenue (TTM)
- $0.00
- Net income (TTM)
- −$10.99M
- Shares outstanding
- 4.4M
- Dividend yield
- —
- 52-week range
- $279.07 – $360.34
Kiora Pharmaceuticals's market cap is $1.51B, based on a share price of $340.75 and 4.4M shares outstanding as of Jun 30, 2026.
Financials
Kiora Pharmaceuticals reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Kiora Pharmaceuticals reported a net loss of $10.84M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | −100.0% | −$10.84M | — | −$2.64 | −$10.07M |
| FY2024ended Dec 31, 2024 | $16.02M | — | $3.59M | 22.4% | $0.87 | $8.55M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$12.51M | — | −$24.25 | −$9.56M |
| FY2021ended Dec 31, 2021 | $0.00 | −100.0% | −$13.77M | — | −$4,631.36 | −$10.74M |
| FY2020ended Dec 31, 2020 | $12.06K | −99.6% | −$6.86M | −56,901.7% | −$4,832.44 | −$7.34M |
| FY2019ended Dec 31, 2019 | $2.69M | +62.5% | −$7.10M | −264.2% | −$7,232.44 | −$8.15M |
| FY2018ended Dec 31, 2018 | $1.65M | +305.5% | −$10.81M | −654.2% | −$14,821.64 | −$10.86M |
| FY2017ended Dec 31, 2017 | $407.52K | −39.1% | −$13.22M | −3,243.5% | −$3,016.22 | −$6.51M |
| FY2016ended Dec 31, 2016 | $669.26K | — | — | — | −$4,897.30 | −$8.41M |
| FY2015ended Dec 31, 2015 | $0.00 | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2025ended Dec 31, 2025 | $0.00 | −$6.52M | −$1.59 |
| Q3 FY2025ended Sep 30, 2025 | $0.00 | $26.81K | $0.01 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$2.15M | −$0.54 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$2.19M | −$0.52 |
| Q4 FY2024ended Dec 31, 2024 | $0.00 | −$4.22M | −$1.25 |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$3.41M | −$0.81 |
| Q2 FY2024ended Jun 30, 2024 | $20.00K | — | — |
| Q1 FY2024ended Mar 31, 2024 | $16.00M | — | — |
Company profile
- Name
- Kiora Pharmaceuticals, Inc.
- Ticker
- KPRX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 169 Saxony Rd., Suite 212, Encinitas, CA 92024
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001372514
Recent SEC filings
- Sep 8, 2026
- Aug 19, 2026
- Aug 7, 2026
- Aug 7, 2026
- Jun 18, 2026
- Jun 11, 2026
- May 8, 2026
- May 8, 2026
Frequently asked questions
What is Kiora Pharmaceuticals's stock price?
Kiora Pharmaceuticals (KPRX) closed at $340.75 on Oct 9, 2026, up 1.29% from the previous close of $336.41.
What is Kiora Pharmaceuticals's market cap?
Kiora Pharmaceuticals's market cap is $1.51B, based on a share price of $340.75 and 4.4M shares outstanding as of Jun 30, 2026.
How much revenue does Kiora Pharmaceuticals make?
Kiora Pharmaceuticals reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.
Does Kiora Pharmaceuticals pay a dividend?
Kiora Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Kiora Pharmaceuticals, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures